Product Program year 2021 Source: CMS Open Payments

Quadra Allure MP RF CRT Pacemkr

Device Cardiac Rhythm Management

PDI 05414734510097

Open in the dashboard

General payments

$30,951

635 payments

Research payments

$815

1 payment

Through program year 2021, $30,951 in general payments and $815 in research payments were reported against Quadra Allure MP RF CRT Pacemkr (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $30,951 635
2021 Research $815 1

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $30,951 635 payments
Top recipients General payments · program year 2021
  1. Antony Kim Cardiovascular Disease · Tacoma, WA $1,403 5% · 7 payments
  2. Oluwakunle Oluwatosin Interventional Cardiology · Osage Beach, MO $1,381 4% · 8 payments
  3. Amardeep Mann Cardiovascular Disease · Pasco, WA $1,341 4% · 6 payments
  4. Arthur Lee Interventional Cardiology · San Jose, CA $1,242 4% · 8 payments
  5. Jeffrey Mahoney Clinical Cardiac Electrophysiology · Omaha, NE $604 2% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $8,609 28% · 90 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $8,563 28% · 136 practitioners
  3. Interventional Cardiology Internal Medicine $6,369 21% · 51 practitioners
  4. Internal Medicine $1,947 6% · 17 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $1,440 5% · 29 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Florida $5,717 18% · 55 recipients
  2. Texas $5,161 17% · 74 recipients
  3. California $3,250 10% · 20 recipients
  4. Washington $2,761 9% · 3 recipients
  5. New York $1,891 6% · 33 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

635 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record